1.	Phase III Randomized Study of Venlafaxine for Hot Flashes in Women with Prior Breast Cancer (Summary Last Modified 01/2000) Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-979254, NCI-P98-0135
2.	Phase III Randomized Study of Medroxyprogesterone Versus Venlafaxine in Women With Symptomatic Hot Flashes Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N99C7, NCI-P02-0204, NCT00030914
3.	Phase III Randomized Study of Soy Protein/Isoflavones and Venlafaxine on Vasomotor Symptoms in Patients With Prostate Cancer Undergoing Hormonal Manipulation Phase: Phase III Type: Supportive care Status: Closed Age: 21 and over Sponsor: NCI Protocol IDs: CCCWFU-97405, CCCWFU 97405, WFU-97405, CCCWFU-BG05-529, NCT00354432
4.	Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer Phase: No phase specified Type: Supportive care Status: Completed Age: 18 to 65 Sponsor: Other Protocol IDs: CDR0000365502, MGH-DFCI-02311, DFCI-02311, NCT00084669